+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
Healthy Volunteers
ID07667621

Open-Label Study of Rimegepant Oral Tablet or Zavegepant Nasal Spray for Acute Migraine Treatment in the Emergency Department

Led by University of South Florida · Updated on 2026-10-27

100

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effectiveness and safety of two medications, rimegepant and zavegepant, for the acute treatment of migraine during a single visit to the Emergency Department. This prospective, open-label, non-controlled pilot study involves two parallel trials without placebo or active comparator groups. The aim is to examine pain relief provided by either rimegepant or zavegepant in separate groups of adult participants. Participants receive a single dose of either rimegepant 75 mg as an orally disintegrating tablet placed on or under the tongue or zavegepant 10 mg as an intranasal spray into one nostril. Both treatments are given during the Emergency Department visit according to FDA-approved instructions. The study does not compare the two drugs directly but evaluates each independently. After treatment, participants will be followed up by telephone for 28 days post-discharge. During the study, participants will be assessed for pain relief at 2 hours after taking the study medication without use of rescue medication, which is the primary outcome. Secondary measures include pain relief at 2 hours with or without rescue medication and early pain relief at 60 minutes. Participants must be available for follow-up calls after discharge. The total participation includes the single Emergency Department visit and 28 days of post-discharge monitoring to evaluate treatment outcomes and safety.

CONDITIONS

Brief Title

A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants for Acute Treatment of Migraine in the Emergency Department

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here